EN3348
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EN3348, covering 2014-09-11 to 2014-09-11. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer [Phase 3]